Mipharm SPA

Mipharm SPA, also known as Mipharm S.p.A., is a pharmaceutical company headquartered in Milan, Italy. The specific nature of its core pharmaceutical products or services, its operational scope beyond Italy, and the precise markets it serves are not detailed in the available source material. Similarly, information regarding the company's scale, such as its size, workforce, or geographical reach beyond its Milan headquarters, is absent from the provided context. No explicit details are available concerning any distinguishing attributes like specialisations, regulatory roles, specific sector positioning, or notable competencies that would set Mipharm apart within the pharmaceutical industry. The ownership structure of Mipharm SPA, including whether it operates as a standalone entity, a subsidiary, or has subsidiaries of its own, is also not mentioned in the known incident report.

The organisation gained public attention due to a significant cybersecurity incident. On April 26, 2021, Mipharm SPA fell victim to a cyberattack attributed to the Sodinokibi ransomware group, also known as REvil. This attack resulted in the theft of sensitive company data from the Milan-based firm. As proof of the successful breach, the attackers publicly disclosed screenshots of the compromised information. While the disclosure confirmed data exfiltration, the specific nature and full extent of the stolen sensitive data were not elaborated upon in the source material. This incident involving Mipharm SPA was reported concurrently with separate claims by the Avaddon ransomware group targeting another pharmaceutical entity named MSpharma located in Jordan; however, the validity of the attack on MSpharma remained unconfirmed at the time of the initial reporting concerning Mipharm. The confirmed breach underscores the cybersecurity risks faced by entities within the pharmaceutical sector.